Your browser doesn't support javascript.
loading
Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score.
Labouret, Mathilde; Trebossen, Vincent; Ntorkou, Alexandra; Bartoli, Sophie; Aubart, Mélodie; Auvin, Stéphane; Bader-Meunier, Brigitte; Baudouin, Véronique; Corseri, Olivier; Dingulu, Glory; Ducrocq, Camille; Dumaine, Cécile; Elmaleh, Monique; Fabien, Nicole; Faye, Albert; Hau, Isabelle; Hentgen, Véronique; Kwon, Théresa; Meinzer, Ulrich; Ouldali, Naim; Parmentier, Cyrielle; Pouletty, Marie; Renaldo, Florence; Savioz, Isabelle; Benoist, Jean-François; Le Roux, Enora; Ellul, Pierre; Melki, Isabelle.
Afiliação
  • Labouret M; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
  • Trebossen V; Sorbonne Université, Paris, France.
  • Ntorkou A; Department of Child and Adolescent Psychiatry, Robert Debré Mother-Child University Hospital, AP-HP, Paris, France.
  • Bartoli S; Université Paris Cité, UFR de Médecine Paris Nord, Paris, France.
  • Aubart M; Department of Paediatric Radiology, Robert Debré Mother-Child University Hospital, AP-HP, Paris, France.
  • Auvin S; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
  • Bader-Meunier B; Paediatric Neurology Department, Necker-Enfants Malades Hospital, University of Paris-Cité, AP-HP, Paris, France.
  • Baudouin V; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, French Institute of Health and Medical Research U1163, Imagine Institute, University of Paris-Cité, Paris, France.
  • Corseri O; Department of Paediatric Neurology, Center for Rare Epilepsies & Epilepsy Unit, Robert Debré Mother-Child University Hospital, AP-HP, Paris, France.
  • Dingulu G; Université Paris Cité, INSERM NeuroDiderot, Paris, France.
  • Ducrocq C; Institut Universitaire de France (IUF), Paris, France.
  • Dumaine C; Department of Paediatric Haematology-Immunology And Rheumatology, Necker-Enfants-Malades University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
  • Elmaleh M; Laboratory of Immunogenetics of Paediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Université Paris Cité, Paris, France.
  • Fabien N; Department of Paediatric Nephrology, Robert Debré Mother-Child University Hospital, AP-HP, Paris, France.
  • Faye A; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
  • Hau I; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
  • Hentgen V; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
  • Kwon T; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
  • Meinzer U; Department of Paediatric Radiology, Robert Debré Mother-Child University Hospital, AP-HP, Paris, France.
  • Ouldali N; Immunology Department, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Lyon, France.
  • Parmentier C; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
  • Pouletty M; Université Paris Cité, UFR de Médecine Paris Nord, Paris, France.
  • Renaldo F; UMR1123 Inserm, Université Paris Cité, Paris, France.
  • Savioz I; Department of General Paediatrics, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
  • Benoist JF; Department of General Paediatrics, French Reference centre for Autoinflammatory diseases and amyloidosis (CEREMAIA), Versailles Hospital, Le Chesnay, France.
  • Le Roux E; Department of Paediatric Nephrology, Robert Debré Mother-Child University Hospital, AP-HP, Paris, France.
  • Ellul P; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
  • Melki I; Université Paris Cité, UFR de Médecine Paris Nord, Paris, France.
Lupus ; 33(4): 328-339, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38315109
ABSTRACT

OBJECTIVE:

Juvenile systemic lupus erythematosus (j-SLE) is a rare chronic auto-immune disease involving several organs. Neuropsychiatric (NP) SLE (NPSLE) is frequent in j-SLE and associated with increased morbidity/mortality. Although NPSLE classification criteria exist, attributing NP features to j-SLE remains a major challenge. The study objective is to thoroughly describe j-NPSLE patients and assist in their diagnosis.

METHODS:

This is a 4-year retrospective monocentric study of j-SLE patients. NP events were attributed to j-SLE using standardised diagnostic criteria and multidisciplinary paediatric clinical expertise. Clinical features, brain magnetic resonance imaging (MRI)s and samples analysis including cerebrospinal fluid were assessed. A risk of j-NPSLE score was developed based on multivariable logistic regression analysis.

RESULTS:

Of 39 patients included, 44% were identified as having j-NPSLE. J-NPSLE diagnosis was established at the onset of j-SLE in 59% of patients. In addition to frequent kidney involvement (76%) and chilblains (65%), all j-NPSLE patients displayed psychiatric features cognitive symptoms (82%), hallucinations (76%), depressed mood (35%), acute confused state (18%) and catatonia (12%). Neurological involvement was often mild and nonspecific, with headache (53%) in about half of the patients. The main features reported on brain MRI were nonspecific T2/FLAIR white matter hyperintensities (65%), and cerebral atrophy (88%). Upon immunosuppressive treatment, clinical improvement of NP features was observed in all j-NPSLE patients. The score developed to attribute j-NPSLE probability, guide further investigations and appropriate treatments is based on hallucinations, memory, sleep and renal involvement (Sensitivity 0.95 Specificity 0.85). Cerebrospinal fluid (CSF) neopterin assessment increases the score sensitivity and specificity.

CONCLUSION:

Physicians should carefully and systematically assess the presence of NP features at diagnosis and early stages of j-SLE. For j-NPSLE patients with predominant psychiatric features, a multidisciplinary collaboration, including psychiatrists, is essential for the diagnosis, management and follow-up.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasculite Associada ao Lúpus do Sistema Nervoso Central / Lúpus Eritematoso Sistêmico Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasculite Associada ao Lúpus do Sistema Nervoso Central / Lúpus Eritematoso Sistêmico Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article